Akari Therapeutics Rally Continues As William Blair Upgrades By: Benzinga via Benzinga September 22, 2017 at 13:42 PM EDT William Blair upgraded shares of Akari Therapeutics PLC (ADR) (NASDAQ: AKTX), given the $73 billion enterprise value of Akari, which ... Read More >> Related Stocks: Akari Therapeutics ADR